Brentuximab Vedotin
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
Year introduced: 2020 (2010)
PubMed search builder options
Subheadings:
Tree Number(s): D12.644.456.217, D12.776.124.486.485.114.224.060.438, D12.776.124.790.651.114.224.060.469, D12.776.377.715.548.114.224.200.469
MeSH Unique ID: D000079963
Registry Number: 7XL5ISS668
Entry Terms:
- SGN-35
- SGN35
- SGN 35
- Adcetris
- CAC10-1006
- CAC101006
- CAC10 1006
- cAC10-vcMMAE
- cAC10vcMMAE
- cAC10 vcMMAE
Pharmacologic Action: